letrozole has been researched along with Low Back Pain in 1 studies
Low Back Pain: Acute or chronic pain in the lumbar or sacral regions, which may be associated with musculo-ligamentous SPRAINS AND STRAINS; INTERVERTEBRAL DISK DISPLACEMENT; and other conditions.
Excerpt | Relevance | Reference |
---|---|---|
"Letrozole was discontinued after 5." | 2.82 | Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature. ( Lüthje, P; Nurmi-Lüthje, I, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Nurmi-Lüthje, I | 2 |
Lüthje, P | 2 |
1 review available for letrozole and Low Back Pain
Article | Year |
---|---|
Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature.
Topics: Aged; Bone Density; Bone Density Conservation Agents; Calcium; Denosumab; Diphosphonates; Female; Hu | 2022 |
Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature.
Topics: Aged; Bone Density; Bone Density Conservation Agents; Calcium; Denosumab; Diphosphonates; Female; Hu | 2022 |
Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature.
Topics: Aged; Bone Density; Bone Density Conservation Agents; Calcium; Denosumab; Diphosphonates; Female; Hu | 2022 |
Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature.
Topics: Aged; Bone Density; Bone Density Conservation Agents; Calcium; Denosumab; Diphosphonates; Female; Hu | 2022 |